Charles Schwab Investment Management Inc. Grows Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

Charles Schwab Investment Management Inc. grew its position in Phibro Animal Health Co. (NASDAQ:PAHC) by 0.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 268,393 shares of the company’s stock after buying an additional 426 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.66% of Phibro Animal Health worth $6,044,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Brandes Investment Partners LP grew its stake in shares of Phibro Animal Health by 1.2% in the second quarter. Brandes Investment Partners LP now owns 2,405,629 shares of the company’s stock worth $40,521,000 after acquiring an additional 29,071 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Phibro Animal Health by 5.7% during the second quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock worth $13,005,000 after purchasing an additional 42,086 shares in the last quarter. Acadian Asset Management LLC lifted its position in Phibro Animal Health by 6.3% in the second quarter. Acadian Asset Management LLC now owns 717,506 shares of the company’s stock valued at $12,027,000 after acquiring an additional 42,299 shares during the last quarter. Dana Investment Advisors Inc. increased its position in shares of Phibro Animal Health by 17.2% during the second quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company’s stock worth $8,619,000 after purchasing an additional 75,546 shares in the last quarter. Finally, American Century Companies Inc. lifted its holdings in shares of Phibro Animal Health by 119.6% in the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock valued at $5,822,000 after purchasing an additional 189,068 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Price Performance

Shares of NASDAQ:PAHC opened at $23.96 on Thursday. The firm has a market capitalization of $970.38 million, a price-to-earnings ratio of 55.72, a price-to-earnings-growth ratio of 0.60 and a beta of 0.51. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. The business’s 50 day simple moving average is $23.52 and its 200-day simple moving average is $20.50. Phibro Animal Health Co. has a 12 month low of $10.03 and a 12 month high of $25.98.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 2.00%. The ex-dividend date is Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 111.63%.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on PAHC shares. StockNews.com cut shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Friday, December 6th. Bank of America raised their price target on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a report on Friday, August 30th. Barclays upped their price objective on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th. Finally, JPMorgan Chase & Co. initiated coverage on Phibro Animal Health in a report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 target price for the company.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.